Clinical Trial Update: Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial comparing HAT1 to Calcipotriol in adults with mild-to-moderate chronic plaque psoriasis reports on efficacy and tolerability; the study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Calcipotriol (calcipotriol)
• HAT1 (HAT1)

Snippet

Sponsor: Haus Bioceuticals | Conditions: Psoriasis, Psoriasis Vulgaris | Phase 1, Phase 2 | Status: COMPLETED